Clinical Trial Update: To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the plasma and pulmonary pharmacokinetics of GSK2140944 in bacterial infections; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• GSK2140944

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Bacterial | Phase 1 | Status: COMPLETED